Eye banking and corneal transplantation communicable adverse incidents: Current status and project NOTIFY

Paul J. Dubord, G. Dewey Evans, Marian S. MacSai, Mark J Mannis, David B. Glasser, Douglas M. Strong, Luc Noël, Deirdre Fehily

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

PURPOSE: Evidence of the transmission of disease via donor ocular tissue has been demonstrated for adenocarcincoma, rabies, hepatitis B virus, cytomegalovirus, herpes simplex virus, Creutzfeldt-Jakob disease, and a variety of bacterial and fungal infections. METHODS: Although there is no evidence to date of disease transmission for HIV infection, syphilis, hepatitis C, hepatitis A, tuberculosis, HTLV-1 and -2 infection, active leprosy, active typhoid, smallpox, and active malaria, these entities remain contraindications for transplantation for all eye banks nationally and internationally. The potential sources of contamination include infected donors, during the process of removing tissue from cadaveric donors, the processing environment, and contaminated supplies and reagents used during processing. The transmissions of Herpes simplex virus and HSV via corneal graft have been shown to be responsible for primary graft failure. HSV-1 may also be an important cause of PFG. RESULTS: The long latency period of some diseases, the emergence of new infectious disease, and the reemergence of others emphasize the need for long-term record maintenance and effective tracing capabilities. CONCLUSIONS: The standardization of definitions for adverse events and reactions will be necessary to support the prevention and transmission of disease. International classification of a unique identification system for donors will be increasingly important for vigilance and traceability in cross-national exportation of human cells, tissues, and cellular- and tissue-based products. Opportunities for continuous improvement exist as does the need for constant vigilance and surveillance.

Original languageEnglish (US)
Pages (from-to)1155-1166
Number of pages12
JournalCornea
Volume32
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Corneal Transplantation
Simplexvirus
Eye Banks
Tissue Donors
Human T-lymphotropic virus 2
Transplants
Creutzfeldt-Jakob Syndrome
Human T-lymphotropic virus 1
Smallpox
Hepatitis A
Rabies
Mycoses
Typhoid Fever
Human Herpesvirus 1
Leprosy
Syphilis
Hepatitis C
Cytomegalovirus
Bacterial Infections
Hepatitis B virus

Keywords

  • adverse events and reactions
  • American trypanosomiasis
  • biovigilance
  • chikungunya virus
  • corneal transplantation
  • Creutzfeldt-Jakob disease (CJD)
  • endophthalmitis and microbial keratitis
  • Eye Bank Technical Advisory Group (EBTAG)
  • hepatitis B and C
  • herpesviridae
  • human immunodeficiency virus (HIV) I and II
  • malignancy
  • primary graft failure (PGF)
  • project NOTIFY
  • rabies
  • syphilis
  • trypanosoma Cruzi
  • tuberculosis
  • West Nile Virus

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Dubord, P. J., Evans, G. D., MacSai, M. S., Mannis, M. J., Glasser, D. B., Strong, D. M., ... Fehily, D. (2013). Eye banking and corneal transplantation communicable adverse incidents: Current status and project NOTIFY. Cornea, 32(8), 1155-1166. https://doi.org/10.1097/ICO.0b013e31828f9d64

Eye banking and corneal transplantation communicable adverse incidents : Current status and project NOTIFY. / Dubord, Paul J.; Evans, G. Dewey; MacSai, Marian S.; Mannis, Mark J; Glasser, David B.; Strong, Douglas M.; Noël, Luc; Fehily, Deirdre.

In: Cornea, Vol. 32, No. 8, 08.2013, p. 1155-1166.

Research output: Contribution to journalArticle

Dubord, PJ, Evans, GD, MacSai, MS, Mannis, MJ, Glasser, DB, Strong, DM, Noël, L & Fehily, D 2013, 'Eye banking and corneal transplantation communicable adverse incidents: Current status and project NOTIFY', Cornea, vol. 32, no. 8, pp. 1155-1166. https://doi.org/10.1097/ICO.0b013e31828f9d64
Dubord, Paul J. ; Evans, G. Dewey ; MacSai, Marian S. ; Mannis, Mark J ; Glasser, David B. ; Strong, Douglas M. ; Noël, Luc ; Fehily, Deirdre. / Eye banking and corneal transplantation communicable adverse incidents : Current status and project NOTIFY. In: Cornea. 2013 ; Vol. 32, No. 8. pp. 1155-1166.
@article{3aa6be305fc24576a88d544738427414,
title = "Eye banking and corneal transplantation communicable adverse incidents: Current status and project NOTIFY",
abstract = "PURPOSE: Evidence of the transmission of disease via donor ocular tissue has been demonstrated for adenocarcincoma, rabies, hepatitis B virus, cytomegalovirus, herpes simplex virus, Creutzfeldt-Jakob disease, and a variety of bacterial and fungal infections. METHODS: Although there is no evidence to date of disease transmission for HIV infection, syphilis, hepatitis C, hepatitis A, tuberculosis, HTLV-1 and -2 infection, active leprosy, active typhoid, smallpox, and active malaria, these entities remain contraindications for transplantation for all eye banks nationally and internationally. The potential sources of contamination include infected donors, during the process of removing tissue from cadaveric donors, the processing environment, and contaminated supplies and reagents used during processing. The transmissions of Herpes simplex virus and HSV via corneal graft have been shown to be responsible for primary graft failure. HSV-1 may also be an important cause of PFG. RESULTS: The long latency period of some diseases, the emergence of new infectious disease, and the reemergence of others emphasize the need for long-term record maintenance and effective tracing capabilities. CONCLUSIONS: The standardization of definitions for adverse events and reactions will be necessary to support the prevention and transmission of disease. International classification of a unique identification system for donors will be increasingly important for vigilance and traceability in cross-national exportation of human cells, tissues, and cellular- and tissue-based products. Opportunities for continuous improvement exist as does the need for constant vigilance and surveillance.",
keywords = "adverse events and reactions, American trypanosomiasis, biovigilance, chikungunya virus, corneal transplantation, Creutzfeldt-Jakob disease (CJD), endophthalmitis and microbial keratitis, Eye Bank Technical Advisory Group (EBTAG), hepatitis B and C, herpesviridae, human immunodeficiency virus (HIV) I and II, malignancy, primary graft failure (PGF), project NOTIFY, rabies, syphilis, trypanosoma Cruzi, tuberculosis, West Nile Virus",
author = "Dubord, {Paul J.} and Evans, {G. Dewey} and MacSai, {Marian S.} and Mannis, {Mark J} and Glasser, {David B.} and Strong, {Douglas M.} and Luc No{\"e}l and Deirdre Fehily",
year = "2013",
month = "8",
doi = "10.1097/ICO.0b013e31828f9d64",
language = "English (US)",
volume = "32",
pages = "1155--1166",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Eye banking and corneal transplantation communicable adverse incidents

T2 - Current status and project NOTIFY

AU - Dubord, Paul J.

AU - Evans, G. Dewey

AU - MacSai, Marian S.

AU - Mannis, Mark J

AU - Glasser, David B.

AU - Strong, Douglas M.

AU - Noël, Luc

AU - Fehily, Deirdre

PY - 2013/8

Y1 - 2013/8

N2 - PURPOSE: Evidence of the transmission of disease via donor ocular tissue has been demonstrated for adenocarcincoma, rabies, hepatitis B virus, cytomegalovirus, herpes simplex virus, Creutzfeldt-Jakob disease, and a variety of bacterial and fungal infections. METHODS: Although there is no evidence to date of disease transmission for HIV infection, syphilis, hepatitis C, hepatitis A, tuberculosis, HTLV-1 and -2 infection, active leprosy, active typhoid, smallpox, and active malaria, these entities remain contraindications for transplantation for all eye banks nationally and internationally. The potential sources of contamination include infected donors, during the process of removing tissue from cadaveric donors, the processing environment, and contaminated supplies and reagents used during processing. The transmissions of Herpes simplex virus and HSV via corneal graft have been shown to be responsible for primary graft failure. HSV-1 may also be an important cause of PFG. RESULTS: The long latency period of some diseases, the emergence of new infectious disease, and the reemergence of others emphasize the need for long-term record maintenance and effective tracing capabilities. CONCLUSIONS: The standardization of definitions for adverse events and reactions will be necessary to support the prevention and transmission of disease. International classification of a unique identification system for donors will be increasingly important for vigilance and traceability in cross-national exportation of human cells, tissues, and cellular- and tissue-based products. Opportunities for continuous improvement exist as does the need for constant vigilance and surveillance.

AB - PURPOSE: Evidence of the transmission of disease via donor ocular tissue has been demonstrated for adenocarcincoma, rabies, hepatitis B virus, cytomegalovirus, herpes simplex virus, Creutzfeldt-Jakob disease, and a variety of bacterial and fungal infections. METHODS: Although there is no evidence to date of disease transmission for HIV infection, syphilis, hepatitis C, hepatitis A, tuberculosis, HTLV-1 and -2 infection, active leprosy, active typhoid, smallpox, and active malaria, these entities remain contraindications for transplantation for all eye banks nationally and internationally. The potential sources of contamination include infected donors, during the process of removing tissue from cadaveric donors, the processing environment, and contaminated supplies and reagents used during processing. The transmissions of Herpes simplex virus and HSV via corneal graft have been shown to be responsible for primary graft failure. HSV-1 may also be an important cause of PFG. RESULTS: The long latency period of some diseases, the emergence of new infectious disease, and the reemergence of others emphasize the need for long-term record maintenance and effective tracing capabilities. CONCLUSIONS: The standardization of definitions for adverse events and reactions will be necessary to support the prevention and transmission of disease. International classification of a unique identification system for donors will be increasingly important for vigilance and traceability in cross-national exportation of human cells, tissues, and cellular- and tissue-based products. Opportunities for continuous improvement exist as does the need for constant vigilance and surveillance.

KW - adverse events and reactions

KW - American trypanosomiasis

KW - biovigilance

KW - chikungunya virus

KW - corneal transplantation

KW - Creutzfeldt-Jakob disease (CJD)

KW - endophthalmitis and microbial keratitis

KW - Eye Bank Technical Advisory Group (EBTAG)

KW - hepatitis B and C

KW - herpesviridae

KW - human immunodeficiency virus (HIV) I and II

KW - malignancy

KW - primary graft failure (PGF)

KW - project NOTIFY

KW - rabies

KW - syphilis

KW - trypanosoma Cruzi

KW - tuberculosis

KW - West Nile Virus

UR - http://www.scopus.com/inward/record.url?scp=84880572901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880572901&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e31828f9d64

DO - 10.1097/ICO.0b013e31828f9d64

M3 - Article

C2 - 23676781

AN - SCOPUS:84880572901

VL - 32

SP - 1155

EP - 1166

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 8

ER -